Newsflash

Alcoholism is one of the scourges of society. Many people battle the ill-effects of this illness. There are countless reasons for the illness. It could be psychological or social. It could be personal problems brought on by family troubles or financial problems. Whatever it is, alcoholism has grown more and more over the years. Add to that, the ready availability of alcohol in the market makes the problem more complicated since teens can have access to it. It is not only the alcoholic that is affected by alcoholism but more importantly, his immediate family, friends, colleagues at work and society in general.
 
powered_by.png, 1 kB
Home arrow News Feeds
News Feeds
Liver Disease / Hepatitis News From Medical News Today
Latest Liver Disease / Hepatitis News From Medical News Today.

  • Transplant Program At UT Southwestern University Hospital Recognized For Increasing Organ Donor Rates
    The surgical transplant team at UT Southwestern University Hospital has garnered twin awards for its successful efforts to increase organ donation rates. "Each organ donation is an opportunity for new life, so we are gratified with these recognitions," said Dr. Juan Arenas, chief of surgical transplantation and surgical director for the liver transplant program.

  • Debunking The Detox Myth
    A group of over 300 young UK scientists and engineers who investigated the evidence behind claims made for products and diets, have started a public awareness campaign by publishing a dossier that shows the word "detox" has no meaning outside of the clinical treatment of drug addiction and poisoning. Called the "Detox Dossier", the report describes the findings of the investigation by the Voice of Young Science (VoYS) network of over 300 early career researchers.

  • A Rigorous Method For Liver Biopsy
    Liver biopsy is still considered the gold standard for grading, staging and "stad-ging" the chronic liver disease. In addition, it remains a primary source for acquiring new knowledge on the liver pathology.

  • Dynavax Announces Termination Of Partnership With Merck For HEPLISAV? Hepatitis B Vaccine - All Rights Revert To Dynavax
    Dynavax Technologies Corporation (Nasdaq:DVAX) today announced the termination of a global license and development collaboration agreement with Merck & Co., Inc. for HEPLISAVTM, a Phase 3 hepatitis B virus (HBV) vaccine. All rights to develop and commercialize HEPLISAV revert to Dynavax.

  • Molecular Events Involved In Liver Regeneration
    The ability to regenerate after major tissue damage or surgical intervention is an important property of the liver. Since liver resection is an established therapeutic measure for severe liver diseases, it would be of importance to know which molecular events underly the regenerative process and if they depend on the extent of resection, as indicated in previous studies. The group led by Prof.


[ Back ]

Sponsored Ads

© 2009 Recovery Works
Joomla! is Free Software released under the GNU/GPL License.